Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 69,104 | 59,041 | 53,695 | 55,684 | 55,624 |
| Operating Income | -69,104 | -59,041 | -53,695 | -55,684 | -55,624 |
| Other Income | 10,847 | 11,522 | 8,747 | 7,065 | 7,943 |
| Pre-tax Income | -58,257 | -47,519 | -44,948 | -48,619 | -47,681 |
| Income Tax | -333 | 412 | -205 | -157 | -220 |
| Net Income Continuous | -57,924 | -47,931 | -44,743 | -48,462 | -47,461 |
| Net Income | $-57,924 | $-47,931 | $-44,743 | $-48,462 | $-47,461 |
| EPS Basic Total Ops | -0.75 | -0.62 | -0.65 | -0.73 | -0.72 |
| EPS Basic Continuous Ops | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 |
| EPS Diluted Total Ops | -0.75 | -0.62 | -0.65 | -0.73 | -0.72 |
| EPS Diluted Continuous Ops | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.62 | -0.64 | N/A | N/A |
| EBITDA(a) | $-68,463 | $-58,455 | $-54,324 | $-53,950 | $-55,022 |